business
Regeneron, Sanofi arthritis drug fails Covid-19 study
Biotech company Regeneron said its rheumatoid arthritis drug Kevzara failed to meet the main goals of a US study testing it in the most critically ill Covid-19 patients
Person: Regeneron
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
